Logo Image

Video Shorts

Frederick Howard, MD
1:55
Appropriately Integrating AI Tools Into Breast Pathology Practices
23 days ago
by
Frederick Howard, MD
Claire Harrison, MD
1:01
Targeting CALR Mutations in MPNs
23 days ago
by
Claire Harrison, MD
Lisa Zhang, MD, UCLA Health
1:25
Examining Disease Recurrence in Postpartum Breast Cancer
a month ago
by
Lisa Zhang, MD
Praful Ravi, MB, BChir, MRCP, Dana-Farber Cancer Institute
1:23
How Can Data From PSMAtrack Inform Treatment in mHSPC?
a month ago
by
Praful K. Ravi, MD
How Daraxonrasib Is Shaping the Next Wave of RAS Inhibition in PDAC
1:30
How Daraxonrasib Is Shaping the Next Wave of RAS Inhibition in PDAC
a month ago
by
Andrew Ko, MD
Peter Voorhees, MD
1:14
The Significance of the MajesTEC-9 Trial in R/R Myeloma
a month ago
by
Peter Voorhees, MD
Ashish M. Kamat, MD, MBBS, FACS
0:53
Examining the Safety Profile of Detalimogene Voraplasmid in NMIBC
a month ago
by
Ashish M. Kamat, MD
Two Onc Docs
1:05
Who's Who? With Two Onc Docs!
a month ago
by
Samantha A. Armstrong, MD(+2 more)
Jonathan Lee, MD, MSc and Matthew Nguyen, MD
1:27
ASCO 2026 Conference Check-In: With Jonathan Lee, MD, MSc and Despina Siolas, MD, PhD
a month ago
by
Jonathan Lee, MD, MSc
Kevin Kalinsky, MD, MS, FASCO
1:00
Noting the Clinical Relevance of Sacituzumab Govitecan Plus Pembrolizumab in TNBC
a month ago
by
Kevin Kalinsky, MD, MS
Javier Cortés, MD, PhD
1:40
Highlighting KEYNOTE-522 Data With Pembrolizumab in TNBC
a month ago
by
Javier Cortés, MD, PhD
Assessing Data for In Vivo CAR T-Cell Therapy in Myeloma
1:07
Assessing Data for In Vivo CAR T-Cell Therapy in Myeloma
a month ago
by
Andrew Spencer, MBBS, FRACP, FRCPA, DM
Sara A. Hurvitz, MD, FACP
1:41
Examining the Implications of the VIKTORIA-1 Study 2 Data in PIK3CA-Mutated Breast Cancer
a month ago
by
Sara A. Hurvitz, MD, FACP
Ruta D. Rao, MD
1:37
Explaining the Prognostic Implications of Post-Surgical ctDNA Status in Early TNBC
a month ago
by
Ruta D. Rao, MD
James T. McCormick, DO
1:25
Exploring the Potential Role of AI-Augmented Surgery in CRC
a month ago
by
James T. McCormick, DO
Jonathan Lee, MD, MSc and Matthew Nguyen, MD
0:55
ASCO 2026 Conference Check-In: With Jonathan Lee, MD, MSc and Matthew Nguyen, MD
a month ago
by
Jonathan Lee, MD, MSc
Assessing Luspatercept Data for Anemia in Myelofibrosis
2:35
Assessing Luspatercept Data for Anemia in Myelofibrosis
a month ago
by
Claire Harrison, MD
Charles E. Geyer, MD
0:46
Highlighting the FDA Approval of Post-Neoadjuvant T-DXd for HER2+ Breast Cancer
a month ago
by
Charles E. Geyer, MD
Saranya Chumsri, MD
0:40
Spotlighting the BRIA-ABC Trial of Bria-IMT in Metastatic Breast Cancer
a month ago
by
Saranya Chumsri, MD
Paolo Tarantino, MD, PhD
0:43
Highlighting the DESTINY-Breast09 Trial of T-DXd Plus Pertuzumab in HER2+ Breast Cancer
a month ago
by
Paolo Tarantino, MD
Toni Choueiri, MD, Dana-Farber Cancer Institute
0:45
Integrating Adjuvant Belzutifan Plus Pembrolizumab into the ccRCC Treatment Paradigm
a month ago
by
Toni Choueiri, MD
Mark Garzotto, MD, OHSU
0:44
Examining the Potential Role of Aglatimagene Besadenovec in Prostate Cancer
a month ago
by
Mark Garzotto, MD
Pathology or Pastry at WCCL 2026!
0:52
Pathology or Pastry at WCCL 2026!
a month ago
by
Amy Musiek, MD(+2 more)
WCCL 2026
0:28
Seeing if Experts Can Get on the Same Wavelength at WCCL 2026!
a month ago
by
Jade Cury-Martins, MD, PhD(+1 more)
Jonathan Lee, MD, MSc and Sean Dougherty, MD
0:50
ASCO 2026 Conference Check-In: With Jonathan Lee, MD, MSc and Dr Manju George
a month ago
by
Jonathan Lee, MD, MSc
Marie Beylot-Barry, MD, PhD
1:06
Stopping Mogamulizumab Treatments in Patients with SS After Achieving CR
a month ago
by
Marie Beylot-Barry, MD, PhD
Jacob Stephen Thomas, MD, discusses the use of ipatasertib plus pembrolizumab in head and neck squamous cell carcinoma.
0:37
Highlighting the Efficacy and Safety of Ipatasertib Plus Pembrolizumab in HNSCC
a month ago
by
Jacob Stephen Thomas, MD
Nicholas Zorko, MD, PhD, University of Minnesota
1:40
Examining the Potential Role of B7-H3 Inhibition in Prostate Cancer
a month ago
by
Nicholas Zorko, MD, PhD
Sara M. Tolaney, MD, MPH
0:40
Highlighting the Safety Profile of Sacituzumab Govitecan/Pembrolizumab in TNBC
a month ago
by
Sara M. Tolaney, MD, MPH
Eman E. Ahmed, MB, BCh, Mayo Clinic
0:21
Comparing PSMA PET/CT vs 11C-Choline PET/CT for Disease Progression Monitoring in mCRPC
a month ago
by
Eman E. Ahmed, MB, BCh